Skip to main content
logo
Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
19.95
+0.06 (0.30%)
Oct 2, 2026, 4:00 PM EDT - Market closed

Acadia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
380.48391226.45-61.29-215.98-167.87
Depreciation & Amortization
12.0211.7615.885.552.033.34
Loss (Gain) From Sale of Assets
---146.52---
Loss (Gain) From Sale of Investments
-2.28-5.42-9.3-12.12-6.280.08
Stock-Based Compensation
58.0552.1467.0566.4268.263.62
Other Operating Activities
-240.2-249.88----
Change in Accounts Receivable
-43.14-22.72-0.47-36.072.17-16.12
Change in Inventory
0.33-18.2-49.55-28.812.42-4.21
Change in Accounts Payable
24.47-5.29-1.354.85.87-1.62
Change in Other Net Operating Assets
-29.43-43.5555.5378.2227.54-2.88
Operating Cash Flow
160.32109.84157.7216.7-114.04-125.66
Operating Cash Flow Growth
-14.68%-30.36%844.31%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-14.69-4.69-0.52-0.05--1.12
Sale of Property, Plant & Equipment
--146.52---
Sale (Purchase) of Intangibles
--98.84--40--
Investment in Securities
-62.78-199.04-176.5372.0573.24-69.98
Investing Cash Flow
-77.47-302.56-30.543273.24-71.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
46.8149.886.8525.138.218.16
Financing Cash Flow
46.8149.886.8525.138.218.16

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.060.03-0.09-0.020.010.01
Net Cash Flow
129.72-142.82133.9373.81-32.59-178.59

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
145.63105.15157.216.65-114.04-126.78
Free Cash Flow Growth
-22.16%-33.11%844.01%---
Free Cash Flow Margin
12.79%9.81%16.41%2.29%-22.05%-26.19%
Free Cash Flow Per Share
0.840.620.940.10-0.70-0.79
Levered Free Cash Flow
68.65-153.66270.0828.44-34.96-65.26
Unlevered Free Cash Flow
68.65-153.66270.0828.44-34.96-65.26

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
25.1725.1719.525.852.191.04
Change in Working Capital
-47.77-89.764.1618.1337.99-24.82
SEC Filings: 10-K · 10-Q